ATGDX
Price
$14.09
Change
+$0.04 (+0.28%)
Updated
Oct 17 closing price
Net Assets
2.66B
RERCX
Price
$63.17
Change
-$0.27 (-0.43%)
Updated
Oct 17 closing price
Net Assets
137.72B
Interact to see
Advertisement

ATGDX vs RERCX

Header iconATGDX vs RERCX Comparison
Open Charts ATGDX vs RERCXBanner chart's image
American Century International Gr R6
Price$14.09
Change+$0.04 (+0.28%)
VolumeN/A
Net Assets2.66B
American Funds EUPAC R3
Price$63.17
Change-$0.27 (-0.43%)
VolumeN/A
Net Assets137.72B
ATGDX vs RERCX Comparison Chart in %
View a ticker or compare two or three
VS
ATGDX vs. RERCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATGDX is a Hold and RERCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERCX has more cash in the bank: 138B vs. ATGDX (2.66B). ATGDX pays higher dividends than RERCX: ATGDX (0.70) vs RERCX (0.47). ATGDX was incepted earlier than RERCX: ATGDX (12 years) vs RERCX (23 years). RERCX (1.12) is less costly to investors than ATGDX (0.87). ATGDX is a more actively managed with annual turnover of: 56.00 vs. RERCX (35.00). ATGDX has a lower initial minimum investment than RERCX: ATGDX (0) vs RERCX (250). RERCX annual gain was more profitable for investors over the last year : 10.58 vs. ATGDX (8.72). RERCX return over 5 years is better than : 12.22 vs. ATGDX (2.08).
ATGDXRERCXATGDX / RERCX
Total Expense Ratio0.871.1278%
Annual Report Gross Expense Ratio0.871.1278%
Fund Existence12 years23 years-
Gain YTD15.58721.10874%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.66B138B2%
Annual Yield % from dividends0.700.47148%
Returns for 1 year8.7210.5882%
Returns for 3 years49.9347.47105%
Returns for 5 years2.0812.2217%
Returns for 10 years25.4939.9064%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOPX40.390.51
+1.28%
Patient Opportunity C
ENPSX32.780.38
+1.17%
ProFunds UltraSector Energy Svc
GQJPX11.550.08
+0.70%
GQG Partners Intl Qual Val Fd Inv
MRGJX56.520.27
+0.48%
MFS Core Equity R4
EPDPX13.43-0.13
-0.96%
EuroPac International Dividend Income A